Certain immunophenotypic markers may identify a patient with acute promyelocytic leukemia who may have a worse prognosis. A patient at increased risk for a poor prognosis may benefit from a more aggressive or experimental therapy.
Patient selection: acute promyelocytic anemia (APML)
Immunophenotypes associated with a worse prognosis:
(1) CD56
(2) CD34
(3) CD2
(4) CD15 (may be associated with bcr1 expression)
These combined with a high white blood cell count prior to therapy (> 10,000 per µL) can help to identify a patient who may have a poor prognosis.
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology
ICD-10: ,
